BAFF-R

IRVINE, California, May 29, 2026 PeproMene Bio, Inc. has announced that updated clinical data from its ongoing Phase 1...

SAN FRANCISCO and VANCOUVER, British Columbia, May 26, 2026 Jade Biosciences announced the first participant has been dosed in...